Medications for Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

2 results

  • bosulif

    (Bosutinib)
    Pfizer Laboratories Div Pfizer Inc
    BOSULIF is indicated for treating chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adults and patients aged 1 and older, whether newly diagnosed or resistant/intolerant to prior therapies. It is also used for adult patients with accelerated or blast phases of Ph+ CML who are resistant/intolerant to prior treatments.

  • sprycel

    (dasatinib)
    E.R. Squibb & Sons, L.L.C.
    SPRYCEL (dasatinib) is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML), resistant or intolerant Ph+ CML, and Ph+ acute lymphoblastic leukemia (ALL). It also treats pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.